State registration procedure
Pre-registration research
Drug development, pre-clinical and clinical studies. Preparation of reports confirming the safety, quality and efficacy of the drug.
Preparation of a complete set of documents in the Common Technical Document (CTD) format and submission of the application to the regulatory authority.
Submission of the registration dossier
State registration of medicinal products manufactured in Russia or imported from other countries and intended for circulation within the Russian Federation is a mandatory procedure.
Analysis of the submitted documents by the regulatory authority. Conducting an expert evaluation by an authorized organization of the proposed methods for quality control of the medicinal product and the benefit-risk ratio of the drug's use.
Registration is carried out by the Ministry of Health of Russia based on the results of examinations conducted by a subordinate institution and confirms that the drug has undergone preclinical and clinical trials, its use is not associated with an unacceptable risk to health, the drug has the claimed therapeutic effect, and complies with all legal requirements in the field of medicinal product circulation.
The process of drug registration is quite lengthy and includes several stages
Making a decision on the registration or refusal to register the drug.